文献库搜索 | GeneLibs

Liu(M),Sun(Y),Wang(S),Jiang(Z) BMC Gastroenterol 2026-02-09

...ALK, CD21, cytokeratin (CK), Desmin, Sox-10, Calretinin, Myoglobin, CD1a, HMB45, Melan-A and STAT6. Based on these findi...

Eshet(Y),Domachevsky(L),Tau(N),Founshtein(... PLoS One None

...ALK) or ROS Proto-Oncogene 1 (ROS1) positive non-small cell lung cancer (NSCLC). We aimed to evaluate the incidence of t...

Gu(SH) Arch Insect Biochem Physiol 2026-07-00

...Alk), fibroblast growth factor (Fgf)/Fgf receptor (Fgfr), neurotrophin (NT), and Toll-receptor ligands (spätzle family m...

Yang(H),Zheng(S),Pang(J),Yu(J),Wang(L) Thorac Cancer 2026-07-00

...ALK) rearrangements are rare in lung squamous cell carcinoma (LSCC), with the clinical efficacy of ALK tyrosine kinase i...

Sharma(M),Byran(G),Balachandran(H),Rajagop... Mini Rev Med Chem 2026-07-17

...ALK), while therapeutic efficacy depends on both catalytic inhibition and trapping mechanisms. Emerging strategies targe...

Greenberger(S),Bar-Ilan(E),Marcu(V),Grishi... Pediatr Blood Cancer 2026-09-00

...ALK, NUP214::FRK, and a novel PICALM::JAK2 fusion not previously described in pcALCL. Clinical courses ranged from spont...

Le(H),Ladino(D),Lowry(C),Rifi(N),Baijal(S) Lung Cancer Manag 2026-12-00

...ALK tyrosine kinase inhibitors (TKIs). We built an economic model to estimate the annual costs of managing ALK+ aNSCLC p...

Liang(L),Shen(M),Qin(C),Liu(C),Huang(C),We... Sci Rep 2026-07-21

...ALK mutations from 2010 to 2023. Specifically, 220 patients with LC and BM harboring EGFR or ALK mutations comprised the...

Wu(TY),Liu(NT),Wu(YC),Liu(CH) Lung Cancer 2026-09-00

...ALK) rearrangements drive approximately 5% of non-small cell lung cancers (NSCLC), most commonly as EML4-ALK, but rare 5...

Yuan(C),Shi(Y),Liu(X),Zhao(Y),Ruan(Z),Luo(... Int J Biol Macromol 2026-06-00

...ALK might overcome the therapeutic bottleneck of PDAC. In this study, we developed a novel dual-targeted nanoformulation...